Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised about $500 million privately, has a drug in Phase 2 testing.

The issue, which has a price band set between ₹275-290 per share for its initial offering, is set to open for public ...

The Quadrant Future Tek IPO was subscribed 48.99 times as of 5:00 PM IST on the second day of its offering, according to data ...

Indobell Insulation’s IPO, worth ₹10.14 crore, was fully subscribed on its first day. The offering is priced at ₹46 per share ...

The main difference between going public through an initial public offering (IPO) and staying private lies in ownership ...

Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Medical technology firm Brainlab AG has asked for bank proposals for its potential initial public offering in Frankfurt, ...

The share sale window of OrbiMed-backed Laxmi Dental will open on Monday, January 13, 2025, to raise Rs 698 crore and will ...

Smithfield Foods on Monday made public its paperwork for its New York initial public offering as the maker of Farmland bacon ...

Nice One Beauty Digital Marketing Co. surged in its debut after a $320 million initial public offering in Riyadh, the latest ...

The initial public offering (IPO) of BR Goyal, an infrastructure and construction company, opened for subscription on January ...